{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:16Z","timestamp":1786982776890,"version":"build-2736575974"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40272-024-00620-2","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T08:01:26Z","timestamp":1710144086000},"page":"245-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment Options for Alopecia Areata in Children and Adolescents"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-9399","authenticated-orcid":false,"given":"Linnea L.","family":"Westerkam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-6528","authenticated-orcid":false,"given":"Diana B.","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9950-1053","authenticated-orcid":false,"given":"Elizabeth L.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-8215","authenticated-orcid":false,"given":"Dean S.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"issue":"4","key":"620_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2013.464","volume":"134","author":"SA Mirzoyev","year":"2014","unstructured":"Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990\u20132009. J Invest Dermatol. 2014;134(4):1141\u20132. https:\/\/doi.org\/10.1038\/jid.2013.464. (Epub 2013 Nov 11).","journal-title":"J Invest Dermatol"},{"issue":"5","key":"620_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1468-3083.2008.02956.x","volume":"23","author":"KP Kyriakis","year":"2009","unstructured":"Kyriakis KP, Paltatzidou K, Kosma E, Sofouri E, Tadros A, Rachioti E. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol. 2009;23(5):572\u20133. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02956.x. (Epub 2008 Sep 3).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"620_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jamadermatol.2022.0351","volume":"158","author":"PL McKenzie","year":"2022","unstructured":"McKenzie PL, Maltenfort M, Bruckner AL, Gupta D, Harfmann KL, Hyde P, Forrest CB, Castelo-Soccio L. Evaluation of the prevalence and incidence of pediatric alopecia areata using electronic health record data. JAMA Dermatol. 2022;158(5):547\u201351. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0351.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"620_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jaad.2021.08.050","volume":"87","author":"NS Ali","year":"2022","unstructured":"Ali NS, Tollefson MM, Lohse CM, Torgerson RR. Incidence and comorbidities of pediatric alopecia areata: a retrospective matched cohort study using the Rochester Epidemiology Project. J Am Acad Dermatol. 2022;87(2):427\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2021.08.050. (Epub 2021 Sep 4).","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"620_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jaad.2017.06.035","volume":"77","author":"CC Caldwell","year":"2017","unstructured":"Caldwell CC, Saikaly SK, Dellavalle RP, Solomon JA. Prevalence of pediatric alopecia areata among 572,617 dermatology patients. J Am Acad Dermatol. 2017;77(5):980\u20131. https:\/\/doi.org\/10.1016\/j.jaad.2017.06.035.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"620_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jaad.2017.04.1141.","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"620_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/s0190-9622(99)70195-7","volume":"40","author":"E Olsen","year":"1999","unstructured":"Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol. 1999;40(2 Pt 1):242\u20136. https:\/\/doi.org\/10.1016\/s0190-9622(99)70195-7.","journal-title":"J Am Acad Dermatol"},{"key":"620_CR8","doi-asserted-by":"publisher","unstructured":"Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King LE Jr, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D; National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines\u2014Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004;51(3):440\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2003.09.032.","DOI":"10.1016\/j.jaad.2003.09.032"},{"key":"620_CR9","unstructured":"Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King LE Jr, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D. Severity of Alopecia Tool (SALT) scoring tool."},{"issue":"3","key":"620_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","volume":"61","author":"C Zhou","year":"2021","unstructured":"Zhou C, Li X, Wang C, Zhang J. Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021;61(3):403\u201323. https:\/\/doi.org\/10.1007\/s12016-021-08883-0. (Epub 2021 Aug 17).","journal-title":"Clin Rev Allergy Immunol"},{"key":"620_CR11","unstructured":"Commissioner, O. of the. 2022.\u00a0FDA approves first systemic treatment for alopecia areata. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-systemic-treatment-alopecia-areata. Accessed 12 Sept 2023."},{"key":"620_CR12","unstructured":"Highlights of prescribing information. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/215830s000lbl.pdf. Accessed 4 Sept 2024."},{"issue":"6","key":"620_CR13","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jaad.2021.04.077","volume":"86","author":"VR Barton","year":"2022","unstructured":"Barton VR, Toussi A, Awasthi S, Kiuru M. Treatment of pediatric alopecia areata: a systematic review. J Am Acad Dermatol. 2022;86(6):1318\u201334. https:\/\/doi.org\/10.1016\/j.jaad.2021.04.077. (Epub 2021 Apr 30).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"620_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jamadermatol.2013.5764","volume":"150","author":"P Lenane","year":"2014","unstructured":"Lenane P, Macarthur C, Parkin PC, et al. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial. JAMA Dermatol. 2014;150(1):47\u201350.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"620_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0560.1977.tb00889.x","volume":"4","author":"LF Montes","year":"1977","unstructured":"Montes LF. Topical halcinonide in alopecia areata and in alopecia totalis. J Cutan Pathol. 1977;4(2):47\u201350.","journal-title":"J Cutan Pathol"},{"issue":"1","key":"620_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","volume":"83","author":"N Meah","year":"2020","unstructured":"Meah N, Wall D, York K, Bhoyrul B, Bokhari L, Sigall DA, Bergfeld WF, Betz RC, Blume-Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Donovan J, Eisman S, Farrant P, Green J, Grimalt R, Harries M, Hordinsky M, Irvine AD, Itami S, Jolliffe V, King B, Lee WS, McMichael A, Messenger A, Mirmirani P, Olsen E, Orlow SJ, Piraccini BM, Rakowska A, Reygagne P, Roberts JL, Rudnicka L, Shapiro J, Sharma P, Tosti A, Vogt A, Wade M, Yip L, Zlotogorski A, Sinclair R. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol. 2020;83(1):123\u201330. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.004. (Epub 2020 Mar 9).","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"620_CR17","first-page":"909","volume":"8","author":"KH Chang","year":"2009","unstructured":"Chang KH, Rojhirunsakool S, Goldberg LJ. Treatment of severe alopecia areata with intralesional steroid injections. J Drugs Dermatol. 2009;8(10):909\u201312.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"620_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","volume":"88","author":"E Abell","year":"1973","unstructured":"Abell E, Munro DD. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol. 1973;88(1):55\u20139.","journal-title":"Br J Dermatol"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.2147\/DDDT.S214907","volume":"13","author":"P Suchonwanit","year":"2019","unstructured":"Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777\u201386. https:\/\/doi.org\/10.2147\/DDDT.S214907. (Erratum in: Drug Des Devel Ther. 2020 Feb 10;14:575).","journal-title":"Drug Des Devel Ther."},{"issue":"2","key":"620_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1080\/09546634.2020.1793893","volume":"33","author":"MAE Abdallah","year":"2022","unstructured":"Abdallah MAE, Shareef R, Soltan MY. Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata. J Dermatol Treat. 2022;33(2):1126\u20139.","journal-title":"J Dermatol Treat"},{"issue":"6398","key":"620_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/bmj.287.6398.1015","volume":"287","author":"DA Fenton","year":"1983","unstructured":"Fenton DA, Wilkinson JD. Topical minoxidil in the treatment of alopecia areata. Br Med J (Clin Res Ed). 1983;287(6398):1015\u20137.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3 Pt 2","key":"620_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","volume":"16","author":"VH Price","year":"1987","unstructured":"Price VH. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol. 1987;16(3 Pt 2):730\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"620_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000096924","volume":"214","author":"S Georgala","year":"2007","unstructured":"Georgala S, Befon A, Maniatopoulou E, Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology. 2007;214(1):101\u20132.","journal-title":"Dermatology"},{"issue":"2","key":"620_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/2229-5178.202269","volume":"8","author":"AK Rai","year":"2017","unstructured":"Rai AK. Minoxidil-induced hypertrichosis in a child with alopecia areata. Indian Dermatol Online J. 2017;8(2):147\u20138.","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"620_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0190-9622(81)80077-1","volume":"5","author":"VC Weiss","year":"1981","unstructured":"Weiss VC, West DP, Mueller CE. Topical minoxidil in alopecia areata. J Am Acad Dermatol. 1981;5(2):224\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"620_CR26","unstructured":"Center for Drug Evaluation and Research. (n.d.).\u00a0DRUGS@FDA data files. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drugsfda-data-files. Accessed 12 Sept 2023."},{"issue":"4","key":"620_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamadermatol.2015.4445","volume":"152","author":"BG Craiglow","year":"2016","unstructured":"Craiglow BG, Tavares D, King BA. Topical ruxolitinib for the treatment of alopecia universalis. JAMA Dermatol. 2016;152(4):490\u20131.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"620_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jaad.2017.03.024","volume":"77","author":"CB Bayart","year":"2017","unstructured":"Bayart CB, DeNiro KL, Brichta L, Craiglow BG, Sidbury R. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata. J Am Acad Dermatol. 2017;77(1):167\u201370.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"620_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jaad.2018.02.031","volume":"78","author":"E Putterman","year":"2018","unstructured":"Putterman E, Castelo-Soccio L. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis. J Am Acad Dermatol. 2018;78(6):1207-1209.e1.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"620_CR30","doi-asserted-by":"publisher","first-page":"762","DOI":"10.55519\/JAMC-04-10933","volume":"34","author":"FA Khan","year":"2022","unstructured":"Khan FA, Hussain M, Khan BM, et al. Comparative study between intralesional injection of platelet rich plasma and intra lesional triamcinolone for the treatment of alopecia areata. J Ayub Med Coll Abbottabad. 2022;34(4):762\u20135.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"620_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12437","author":"MA El Taieb","year":"2017","unstructured":"El Taieb MA, Ibrahim H, Nada EA, Seif A-DM. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation. Dermatol Ther. 2017. https:\/\/doi.org\/10.1111\/dth.12437. (Epub 2016 Oct 28).","journal-title":"Dermatol Ther"},{"issue":"3","key":"620_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.bbrc.2018.09.164","volume":"505","author":"HI Choi","year":"2018","unstructured":"Choi HI, Kang BM, Jang J, Hwang ST, Kwon O. Novel effect of sildenafil on hair growth. Biochem Biophys Res Commun. 2018;505(3):685\u201391. https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.164. (Epub 2018 Oct 3).","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"620_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/09546630600895003","volume":"17","author":"E Sarifakioglu","year":"2006","unstructured":"Sarifakioglu E, Degim IT, Gorpelioglu C. Determination of the sildenafil effect on alopecia areata in childhood: An open-pilot comparison study. J Dermatol Treat. 2006;17(4):235\u20137.","journal-title":"J Dermatol Treat"},{"key":"620_CR34","first-page":"419","volume":"10","author":"M Borchert","year":"2016","unstructured":"Borchert M, Bruce S, Wirta D, et al. An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects. Clin Ophthalmol. 2016;10:419\u201329 (Published 2016 Mar 10).","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"620_CR35","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1111\/j.1365-2230.2009.03755.x","volume":"35","author":"S Zaheri","year":"2010","unstructured":"Zaheri S, Hughes B. Successful use of bimatoprost in the treatment of alopecia of the eyelashes. Clin Exp Dermatol. 2010;35(4):e161\u20132.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"620_CR36","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1111\/pde.12920","volume":"33","author":"AW Li","year":"2016","unstructured":"Li AW, Antaya RJ. Successful treatment of pediatric alopecia areata of the scalp using topical bimatoprost. Pediatr Dermatol. 2016;33(5):e282\u20133.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"620_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/sj.eye.6700354","volume":"17","author":"JS Mehta","year":"2003","unstructured":"Mehta JS, Raman J, Gupta N, Thoung D. Cutaneous latanoprost in the treatment of alopecia areata. Eye (Lond). 2003;17(3):444\u20136.","journal-title":"Eye (Lond)"},{"issue":"1","key":"620_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.25259\/IJDVL_787_19","volume":"87","author":"S Bhat","year":"2021","unstructured":"Bhat S, Handa S, De D. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata. Indian J Dermatol Venereol Leprol. 2021;87(1):42\u20138.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"620_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","volume":"24","author":"IM Coronel-P\u00e9rez","year":"2010","unstructured":"Coronel-P\u00e9rez IM, Rodr\u00edguez-Rey EM, Camacho-Mart\u00ednez FM. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol. 2010;24(4):481\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"620_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/09546634.2017.1330527","volume":"29","author":"AA El-Ashmawy","year":"2018","unstructured":"El-Ashmawy AA, El-Maadawy IH, El-Maghraby GM. Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata. J Dermatolog Treat. 2018;29(1):55\u201364.","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"620_CR41","doi-asserted-by":"publisher","first-page":"e1010","DOI":"10.1111\/j.1365-2230.2009.03677.x","volume":"34","author":"S Yadav","year":"2009","unstructured":"Yadav S, Dogra S, Kaur I. An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2. Clin Exp Dermatol. 2009;34(8):e1010\u20131.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"620_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clindermatol.2014.12.001","volume":"33","author":"ND Hill","year":"2015","unstructured":"Hill ND, Bunata K, Hebert AA. Treatment of alopecia areata with squaric acid dibutylester. Clin Dermatol. 2015;33(3):300\u20134.","journal-title":"Clin Dermatol"},{"issue":"5","key":"620_CR43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000249797","volume":"167","author":"A Giannetti","year":"1983","unstructured":"Giannetti A, Orecchia G. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester. Dermatologica. 1983;167(5):280\u20132.","journal-title":"Dermatologica"},{"issue":"2 Pt 1","key":"620_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0190-9622(96)90323-0","volume":"35","author":"A Tosti","year":"1996","unstructured":"Tosti A, Guidetti MS, Bardazzi F, Misciali C. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol. 1996;35(2 Pt 1):199\u2013201.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"620_CR45","first-page":"970","volume":"137","author":"AG Pardasani","year":"2001","unstructured":"Pardasani AG, Turner E, McMichael AJ. Squaric acid dibutylester: indications for use and efficacy in alopecia areata. Arch Dermatol. 2001;137(7):970\u20132.","journal-title":"Arch Dermatol"},{"issue":"9","key":"620_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/archdermatol.2012.1622","volume":"148","author":"JM Salsberg","year":"2012","unstructured":"Salsberg JM, Donovan J. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children. Arch Dermatol. 2012;148(9):1084\u20135.","journal-title":"Arch Dermatol"},{"issue":"4","key":"620_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1365-2133.1996.d01-1044.x","volume":"135","author":"ML Schuttelaar","year":"1996","unstructured":"Schuttelaar ML, Hamstra JJ, Plinck EP, et al. Alopecia areata in children: treatment with diphencyprone. Br J Dermatol. 1996;135(4):581\u20135.","journal-title":"Br J Dermatol"},{"issue":"2","key":"620_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2133.1991.tb06064.x","volume":"125","author":"SM Hull","year":"1991","unstructured":"Hull SM, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol. 1991;125(2):164\u20138.","journal-title":"Br J Dermatol"},{"issue":"3","key":"620_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000249418","volume":"171","author":"G Orecchia","year":"1985","unstructured":"Orecchia G, Rabbiosi G. Treatment of alopecia areata with diphencyprone. Dermatologica. 1985;171(3):193\u20136.","journal-title":"Dermatologica"},{"issue":"3","key":"620_CR50","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1111\/jdv.12009","volume":"27","author":"NM Luk","year":"2013","unstructured":"Luk NM, Chiu LS, Lee KC, et al. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. J Eur Acad Dermatol Venereol. 2013;27(3):e400\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"620_CR51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4103\/0378-6323.37072","volume":"73","author":"G Singh","year":"2007","unstructured":"Singh G, Okade R, Naik C, Dayanand CD. Diphenylcyclopropenone immunotherapy in ophiasis. Indian J Dermatol Venereol Leprol. 2007;73(6):432\u20133.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"620_CR52","first-page":"48","volume":"32","author":"D Sotiriadis","year":"2007","unstructured":"Sotiriadis D, Patsatsi A, Lazaridou E, Kastanis A, Vakirlis E, Chrysomallis F. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Clin Exp Dermatol. 2007;32(1):48\u201351.","journal-title":"Clin Exp Dermatol"},{"issue":"5 Suppl","key":"620_CR53","doi-asserted-by":"publisher","first-page":"35S","DOI":"10.1038\/jid.1995.53","volume":"104","author":"G Orecchia","year":"1995","unstructured":"Orecchia G, Malagoli P. Topical immunotherapy in children with alopecia areata. J Invest Dermatol. 1995;104(5 Suppl):35S-36S.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"620_CR54","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jaad.2015.01.008","volume":"72","author":"M Durdu","year":"2015","unstructured":"Durdu M, \u00d6zcan D, Baba M, Se\u00e7kin D. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. J Am Acad Dermatol. 2015;72(4):640\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"620_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/pde.13049","volume":"34","author":"M \u00d6zdemir","year":"2017","unstructured":"\u00d6zdemir M, Balevi A. Bilateral half-head comparison of 1% anthralin ointment in children with alopecia areata. Pediatr Dermatol. 2017;34(2):128\u201332.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"620_CR56","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/pde.13703","volume":"35","author":"SZ Wu","year":"2018","unstructured":"Wu SZ, Wang S, Ratnaparkhi R, Bergfeld WF. Treatment of pediatric alopecia areata with anthralin: a retrospective study of 37 patients. Pediatr Dermatol. 2018;35(6):817\u201320.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"620_CR57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1525-1470.2010.01191.x","volume":"27","author":"D Torchia","year":"2010","unstructured":"Torchia D, Schachner LA. Bilateral treatment for alopecia areata. Pediatr Dermatol. 2010;27(4):415\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"620_CR58","first-page":"138","volume":"79","author":"PR Letada","year":"2007","unstructured":"Letada PR, Sparling JD, Norwood C. Imiquimod in the treatment of alopecia universalis. Cutis. 2007;79(2):138\u201340.","journal-title":"Cutis"},{"issue":"3","key":"620_CR59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ajd.12478","volume":"58","author":"T Wasy\u0142yszyn","year":"2017","unstructured":"Wasy\u0142yszyn T, Borowska K. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: an observational study of nonresponder patients with alopecia areata. Austral J Dermatol. 2017;58(3):219\u201323.","journal-title":"Austral J Dermatol"},{"issue":"4","key":"620_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/0253-7613.161249","volume":"47","author":"AK Bubna","year":"2015","unstructured":"Bubna AK. Imiquimod - its role in the treatment of cutaneous malignancies. Indian J Pharmacol. 2015;47(4):354\u20139. https:\/\/doi.org\/10.4103\/0253-7613.161249.","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"620_CR61","doi-asserted-by":"publisher","first-page":"592.e1","DOI":"10.1016\/j.jaad.2009.02.037","volume":"61","author":"R Talpur","year":"2009","unstructured":"Talpur R, Vu J, Bassett R, Stevens V, Duvic M. Phase I\/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol. 2009;61(4):592.e1-592.e5929.","journal-title":"J Am Acad Dermatol"},{"key":"620_CR62","doi-asserted-by":"crossref","unstructured":"Jun M, Lee NR, Lee WS. Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years [published correction appears in J Dermatol. 2017 Aug;44(8):985]. J Dermatol. 2017;44(4):386\u201393.","DOI":"10.1111\/1346-8138.13613"},{"issue":"1","key":"620_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0974-7753.179403","volume":"8","author":"VP Zawar","year":"2016","unstructured":"Zawar VP, Karad GM. Liquid nitrogen cryotherapy in recalcitrant alopecia areata: a study of 11 patients. Int J Trichol. 2016;8(1):15\u201320.","journal-title":"Int J Trichol."},{"issue":"2","key":"620_CR64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2230.2006.02061.x","volume":"31","author":"CS Jury","year":"2006","unstructured":"Jury CS, McHenry P, Burden AD, Lever R, Bilsland D. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006;31(2):196\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"620_CR65","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1525-1470.2009.00980.x","volume":"26","author":"N Al-Mutairi","year":"2009","unstructured":"Al-Mutairi N. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol. 2009;26(5):547\u201350.","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"620_CR66","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","volume":"33","author":"N Al-Mutairi","year":"2007","unstructured":"Al-Mutairi N. 308-nm excimer laser for the treatment of alopecia areata. Dermatol Surg. 2007;33(12):1483\u20137.","journal-title":"Dermatol Surg"},{"issue":"5","key":"620_CR67","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","volume":"51","author":"W Zakaria","year":"2004","unstructured":"Zakaria W, Passeron T, Ostovari N, Lacour JP, Ortonne JP. 308-nm excimer laser therapy in alopecia areata. J Am Acad Dermatol. 2004;51(5):837\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 4","key":"620_CR68","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/j.1524-4725.2010.01709.x","volume":"36","author":"HR Cho","year":"2010","unstructured":"Cho HR, Lew BL, Lew H, Sim WY. Treatment effects of intradermal botulinum toxin type A injection on alopecia areata. Dermatol Surg. 2010;36(Suppl 4):2175\u201381.","journal-title":"Dermatol Surg"},{"issue":"2","key":"620_CR69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/pde.15209","volume":"40","author":"NM Gallaga","year":"2023","unstructured":"Gallaga NM, Carrillo B, Good A, Munoz-Gonzalez A, Ross L. Pediatric pulse dose corticosteroid therapy dosing and administration in the treatment of alopecia areata: a review of literature. Pediatr Dermatol. 2023;40(2):276\u201381. https:\/\/doi.org\/10.1111\/pde.15209. (Epub 2022 Dec 2).","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"620_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ddg.12875","volume":"15","author":"K Jahn-Bassler","year":"2017","unstructured":"Jahn-Bassler K, Bauer WM, Karlhofer F, Vossen MG, Stingl G. Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata. J Dtsch Dermatol Ges. 2017;15(1):42\u20137.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"620_CR71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/dth.12255","volume":"28","author":"J Lalosevic","year":"2015","unstructured":"Lalosevic J, Gajic-Veljic M, Bonaci-Nikolic B, Nikolic M. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study. Dermatol Ther. 2015;28(5):309\u201317.","journal-title":"Dermatol Ther"},{"issue":"11","key":"620_CR72","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1111\/jdv.14291","volume":"31","author":"JH Chong","year":"2017","unstructured":"Chong JH, Ta\u00efeb A, Morice-Picard F, Dutkiewicz AS, L\u00e9aut\u00e9-Labr\u00e8ze C, Boralevi F. High-dose pulsed corticosteroid therapy combined with methotrexate for severe alopecia areata of childhood. J Eur Acad Dermatol Venereol. 2017;31(11):e476\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"620_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000051642","volume":"202","author":"S Seiter","year":"2001","unstructured":"Seiter S, Ugurel S, Tilgen W, Reinhold U. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology. 2001;202(3):230\u20134.","journal-title":"Dermatology"},{"issue":"10","key":"620_CR74","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1001\/archderm.1978.01640220035008","volume":"114","author":"WP Unger","year":"1978","unstructured":"Unger WP, Schemmer RJ. Corticosteroids in the treatment of alopecia totalis. Systemic effects. Arch Dermatol. 1978;114(10):1486\u201390.","journal-title":"Arch Dermatol"},{"issue":"9","key":"620_CR75","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1346-8138.1999.tb02049.x","volume":"26","author":"VK Sharma","year":"1999","unstructured":"Sharma VK, Gupta S. Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata. J Dermatol. 1999;26(9):562\u20135.","journal-title":"J Dermatol"},{"issue":"4","key":"620_CR76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/pde.12578","volume":"32","author":"A Smith","year":"2015","unstructured":"Smith A, Tr\u00fceb RM, Theiler M, Hauser V, Weibel L. High relapse rates despite early intervention with intravenous methylprednisolone pulse therapy for severe childhood alopecia areata. Pediatr Dermatol. 2015;32(4):481\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"620_CR77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0378-6323.148608","volume":"81","author":"SC Senila","year":"2015","unstructured":"Senila SC, Danescu SA, Ungureanu L, Candrea E, Cosgarea RM. Intravenous methylprednisolone pulse therapy in severe alopecia areata. Indian J Dermatol Venereol Leprol. 2015;81(1):95.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"620_CR78","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1365-2133.2008.08458.x","volume":"158","author":"T Hubiche","year":"2008","unstructured":"Hubiche T, L\u00e9aut\u00e9-Labr\u00e8ze C, Ta\u00efeb A, Boralevi F. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol. 2008;158(5):1136\u20137.","journal-title":"Br J Dermatol"},{"issue":"5","key":"620_CR79","first-page":"717","volume":"27","author":"GA Bin Saif","year":"2006","unstructured":"Bin Saif GA. Oral mega pulse methylprednisolone in alopecia universalis. Saudi Med J. 2006;27(5):717\u201320.","journal-title":"Saudi Med J"},{"issue":"4 Pt 1","key":"620_CR80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","volume":"39","author":"A Friedli","year":"1998","unstructured":"Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH. Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol. 1998;39(4 Pt 1):597\u2013602.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"620_CR81","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000246159","volume":"194","author":"N Kiesch","year":"1997","unstructured":"Kiesch N, Stene JJ, Goens J, Vanhooteghem O, Song M. Pulse steroid therapy for children\u2019s severe alopecia areata? Dermatology. 1997;194(4):395\u20137.","journal-title":"Dermatology"},{"issue":"4","key":"620_CR82","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000247268","volume":"187","author":"J Perriard-Wolfensberger","year":"1993","unstructured":"Perriard-Wolfensberger J, Pasche-Koo F, Mainetti C, Labarthe MP, Salomon D, Saurat JH. Pulse of methylprednisolone in alopecia areata. Dermatology. 1993;187(4):282\u20135.","journal-title":"Dermatology"},{"issue":"2","key":"620_CR83","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","volume":"52","author":"BR Kar","year":"2005","unstructured":"Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol. 2005;52(2):287\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"620_CR84","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4161\/derm.1.6.11236","volume":"1","author":"P Efentaki","year":"2009","unstructured":"Efentaki P, Altenburg A, Haerting J, Zouboulis CC. Medium-dose prednisolone pulse therapy in alopecia areata. Dermatoendocrinol. 2009;1(6):310\u20133.","journal-title":"Dermatoendocrinol."},{"issue":"4","key":"620_CR85","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1525-1470.1998.tb01348.x","volume":"15","author":"VK Sharma","year":"1998","unstructured":"Sharma VK, Muralidhar S. Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse. Pediatr Dermatol. 1998;15(4):313\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"620_CR86","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/archderm.1976.01630350025006","volume":"112","author":"RJ Winter","year":"1976","unstructured":"Winter RJ, Kern F, Blizzard RM. Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol. 1976;112(11):1549\u201352.","journal-title":"Arch Dermatol"},{"issue":"1","key":"620_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000351559","volume":"227","author":"R Friedland","year":"2013","unstructured":"Friedland R, Tal R, Lapidoth M, Zvulunov A, Ben AD. Pulse corticosteroid therapy for alopecia areata in children: a retrospective study. Dermatology. 2013;227(1):37\u201344.","journal-title":"Dermatology"},{"issue":"9","key":"620_CR88","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/1346-8138.13388","volume":"43","author":"T Yoshimasu","year":"2016","unstructured":"Yoshimasu T, Kanazawa N, Yamamoto Y, Furukawa F. Multiple courses of pulse corticosteroid therapy for alopecia areata. J Dermatol. 2016;43(9):1075\u20137.","journal-title":"J Dermatol"},{"issue":"8","key":"620_CR89","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1365-4362.1998.00422.x","volume":"37","author":"AS Alabdulkareem","year":"1998","unstructured":"Alabdulkareem AS, Abahussein AA, Okoro A. Severe alopecia areata treated with systemic corticosteroids. Int J Dermatol. 1998;37(8):622\u20134.","journal-title":"Int J Dermatol"},{"issue":"2","key":"620_CR90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/1346-8138.13533","volume":"44","author":"J Seo","year":"2017","unstructured":"Seo J, Lee YI, Hwang S, Zheng Z, Kim DY. Intramuscular triamcinolone acetonide: an undervalued option for refractory alopecia areata. J Dermatol. 2017;44(2):173\u20139.","journal-title":"J Dermatol"},{"issue":"1","key":"620_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00455378","volume":"261","author":"R Michalowski","year":"1978","unstructured":"Michalowski R, Kuczy\u0144ska L. Long-term intramuscular triamcinolone-acetonide therapy in alopecia areata totalis and universalis. Arch Dermatol Res. 1978;261(1):73\u20136.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"620_CR92","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2133.2011.10383.x","volume":"165","author":"M Royer","year":"2011","unstructured":"Royer M, Bodemer C, Vabres P, et al. Efficacy and tolerability of methotrexate in severe childhood alopecia areata. Br J Dermatol. 2011;165(2):407\u201310.","journal-title":"Br J Dermatol"},{"issue":"1","key":"620_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2340\/00015555-2173","volume":"96","author":"P Lucas","year":"2016","unstructured":"Lucas P, Bodemer C, Barbarot S, Vabres P, Royer M, Mazereeuw-Hautier J. Methotrexate in severe childhood alopecia areata: long-term follow-up. Acta Derm Venereol. 2016;96(1):102\u20133.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"620_CR94","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/09546634.2017.1341608","volume":"29","author":"ET Landis","year":"2018","unstructured":"Landis ET, Pichardo-Geisinger RO. Methotrexate for the treatment of pediatric alopecia areata. J Dermatol Treat. 2018;29(2):145\u20138.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"620_CR95","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/ijt.ijt_67_16","volume":"8","author":"A Batalla","year":"2016","unstructured":"Batalla A, Fl\u00f3rez \u00c1, Abalde T, V\u00e1zquez-Veiga H. Methotrexate in alopecia areata: a report of three cases. Int J Trichol. 2016;8(4):188\u201390.","journal-title":"Int J Trichol."},{"issue":"5","key":"620_CR96","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/pde.15327","volume":"40","author":"EC Siegfried","year":"2023","unstructured":"Siegfried EC, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, Co DO, Cordoro KM, Curran ML, Dalrymple AM, Flohr C, Gordon KB, Hanna D, Irvine AD, Kim S, Kirkorian AY, Lara-Corrales I, Lindstrom J, Paller AS, Reyes M, Begolka WS, Tom WL, Van Voorhees AS, Vleugels RA, Lee LW, Davies OMT, Brandling-Bennett HA. Methotrexate for inflammatory skin disease in pediatric patients: consensus treatment guidelines. Pediatr Dermatol. 2023;40(5):789\u2013808. https:\/\/doi.org\/10.1111\/pde.15327. (Epub 2023 Jun 14).","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"620_CR97","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/archderm.1987.01660350088019","volume":"123","author":"VC Fiedler-Weiss","year":"1987","unstructured":"Fiedler-Weiss VC, Rumsfield J, Buys CM, West DP, Wendrow A. Evaluation of oral minoxidil in the treatment of alopecia areata. Arch Dermatol. 1987;123(11):1488\u201390.","journal-title":"Arch Dermatol"},{"key":"620_CR98","doi-asserted-by":"publisher","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones \u00d3M, Saceda-Corralo D, Rodrigues-Barata R, Jimenez-Cauhe J, Koh WL, Poa JE, Jerjen R, Trindade de Carvalho L, John JM, Salas-Callo CI, Vincenzi C, Yin L, Lo-Sicco K, Waskiel-Burnat A, Starace M, Zamorano JL, Ja\u00e9n-Olasolo P, Piraccini BM, Rudnicka L, Shapiro J, Tosti A, Sinclair R, Bhoyrul B. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.054. Epub 2021 Feb 24.","DOI":"10.1016\/j.jaad.2021.02.054"},{"key":"620_CR99","unstructured":"Ahmad A, Zaheer M, Balis FJ. Baricitinib\u2014StatPearls\u2014NCBI Bookshelf. Baricitinib. 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572064\/. Accessed 12 Sept 2023."},{"key":"620_CR100","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/dddt.s334727","volume":"16","author":"HA Ram\u00edrez-Mar\u00edn","year":"2022","unstructured":"Ram\u00edrez-Mar\u00edn HA, Tosti A. Evaluating the therapeutic potential of ritlecitinib for the treatment of alopecia areata. Drug Des Dev Ther. 2022;16:363\u201374. https:\/\/doi.org\/10.2147\/dddt.s334727.","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"620_CR101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","volume":"20","author":"AA Zarrin","year":"2021","unstructured":"Zarrin AA, Bao K, Lupardus P, Vucic D. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov. 2021;20(1):39\u201363. https:\/\/doi.org\/10.1038\/s41573-020-0082-8. (Epub 2020 Oct 19).","journal-title":"Nat Rev Drug Discov"},{"key":"620_CR102","doi-asserted-by":"crossref","unstructured":"King B, Zhang X, Harcha WG, et al. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial [published correction appears in Lancet. 2023 Jun 10;401(10392):1928]. Lancet. 2023;401(10387):1518\u201329.","DOI":"10.1016\/S0140-6736(23)00222-2"},{"key":"620_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15378","author":"M Hordinsky","year":"2023","unstructured":"Hordinsky M, Hebert AA, Gooderham M, Kwon O, Murashkin N, Fang H, Harada K, Law E, Wajsbrot D, Takiya L, Zwillich SH, Wolk R, Tran H. Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b\/3 randomized, double-blind, placebo-controlled trial. Pediatr Dermatol. 2023. https:\/\/doi.org\/10.1111\/pde.15378. (Epub ahead of print).","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"620_CR104","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","volume":"2","author":"A Jabbari","year":"2015","unstructured":"Jabbari A, Dai Z, Xing L, et al. Reversal of alopecia areata following treatment with the JAK1\/2 Inhibitor baricitinib. EBioMedicine. 2015;2(4):351\u20135 (Published 2015 Feb 26).","journal-title":"EBioMedicine"},{"issue":"1","key":"620_CR105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","volume":"76","author":"BG Craiglow","year":"2017","unstructured":"Craiglow BG, Liu LY, King BA. Tofacitinib for the treatment of alopecia areata and variants in adolescents. J Am Acad Dermatol. 2017;76(1):29\u201332.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"620_CR106","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jaad.2016.11.038","volume":"76","author":"L Castelo-Soccio","year":"2017","unstructured":"Castelo-Soccio L. Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis. J Am Acad Dermatol. 2017;76(4):754\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"620_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/pde.14855","volume":"39","author":"J Kibbie","year":"2022","unstructured":"Kibbie J, Kines K, Norris D, Dunnick CA. Oral tofacitinib for the treatment of alopecia areata in pediatric patients. Pediatr Dermatol. 2022;39(1):31\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"620_CR108","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jaad.2018.08.041","volume":"80","author":"BG Craiglow","year":"2019","unstructured":"Craiglow BG, King BA. Tofacitinib for the treatment of alopecia areata in preadolescent children. J Am Acad Dermatol. 2019;80(2):568\u201370.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"620_CR109","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jaad.2018.12.041","volume":"80","author":"YX Dai","year":"2019","unstructured":"Dai YX, Chen CC. Tofacitinib therapy for children with severe alopecia areata. J Am Acad Dermatol. 2019;80(4):1164\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"620_CR110","first-page":"914","volume":"17","author":"L Brown","year":"2018","unstructured":"Brown L, Skopit S. An excellent response to tofacitinib in a pediatric alopecia patient: a case report and review. J Drugs Dermatol. 2018;17(8):914\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"620_CR111","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1203475418760512","volume":"22","author":"NU Patel","year":"2018","unstructured":"Patel NU, Oussedik E, Grammenos A, Pichardo-Geisinger R. A case report highlighting the effective treatment of alopecia universalis with tofacitinib in an adolescent and adult patient. J Cutan Med Surg. 2018;22(4):439\u201342.","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"620_CR112","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jaad.2018.11.037","volume":"80","author":"LY Liu","year":"2019","unstructured":"Liu LY, King BA. Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata. J Am Acad Dermatol. 2019;80(6):1778\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"620_CR113","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/ccr3.2484","volume":"7","author":"R Berbert Ferreira","year":"2019","unstructured":"Berbert Ferreira R, Ferreira SB, Scheinberg MA. An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: a case report and a review of the literature. Clin Case Rep. 2019;7(12):2539\u201342 (Published 2019 Nov 21).","journal-title":"Clin Case Rep."},{"issue":"9","key":"620_CR114","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1111\/jocd.13966","volume":"20","author":"D Dincer Rota","year":"2021","unstructured":"Dincer Rota D, Emeksiz MAC, Erdogan FG, Yildirim D. Experience with oral tofacitinib in severe alopecia areata with different clinical responses. J Cosmet Dermatol. 2021;20(9):3026\u201333.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"620_CR115","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/pde.14422","volume":"38","author":"R Jerjen","year":"2021","unstructured":"Jerjen R, Meah N, de Carvalho LT, Wall D, Eisman S, Sinclair R. Treatment of alopecia areata in pre-adolescent children with oral tofacitinib: a retrospective study. Pediatr Dermatol. 2021;38(1):103\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"620_CR116","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13118","volume":"32","author":"N Akdogan","year":"2019","unstructured":"Akdogan N, Ersoy-Evans S, Do\u011fan S, Atakan N. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata. Dermatol Ther. 2019;32(6): e13118.","journal-title":"Dermatol Ther"},{"issue":"2","key":"620_CR117","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jaad.2018.08.040","volume":"80","author":"LY Liu","year":"2019","unstructured":"Liu LY, King BA. Ruxolitinib for the treatment of severe alopecia areata. J Am Acad Dermatol. 2019;80(2):566\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"620_CR118","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2021.01.046","volume":"84","author":"PL McKenzie","year":"2021","unstructured":"McKenzie PL, Castelo-Soccio L. Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis. J Am Acad Dermatol. 2021;84(6):1691\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"620_CR119","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4161\/mabs.3.6.17815","volume":"3","author":"JM Benson","year":"2011","unstructured":"Benson JM, Peritt D, Scallon BJ, Heavner GA, Shealy DJ, Giles-Komar JM, Mascelli MA. Discovery and mechanism of ustekinumab. MAbs. 2011;3(6):535\u201345. https:\/\/doi.org\/10.4161\/mabs.3.6.17815.","journal-title":"MAbs"},{"issue":"1","key":"620_CR120","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1111\/pde.13699","volume":"36","author":"A Aleisa","year":"2019","unstructured":"Aleisa A, Lim Y, Gordon S, et al. Response to ustekinumab in three pediatric patients with alopecia areata. Pediatr Dermatol. 2019;36(1):e44\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"620_CR121","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.0022-202X.2005.10130_6.x","volume":"10","author":"S Skurkovich","year":"2005","unstructured":"Skurkovich S, Korotky NG, Sharova NM, Skurkovich B. Treatment of alopecia areata with anti-interferon-gamma antibodies. J Investig Dermatol Symp Proc. 2005;10(3):283\u20134.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"4","key":"620_CR122","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaad.2017.05.034","volume":"77","author":"LY Liu","year":"2017","unstructured":"Liu LY, King BA. Lack of efficacy of apremilast in 9 patients with severe alopecia areata. J Am Acad Dermatol. 2017;77(4):773\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"620_CR123","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/09546630701846095","volume":"19","author":"BJ Kim","year":"2008","unstructured":"Kim BJ, Min SU, Park KY, et al. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat. 2008;19(4):216\u201320.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"620_CR124","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/jidsymp.2013.23","volume":"16","author":"RC Gensure","year":"2013","unstructured":"Gensure RC. Clinical response to combined therapy of cyclosporine and prednisone. J Investig Dermatol Symp Proc. 2013;16(1):S58.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"9","key":"620_CR125","first-page":"1012","volume":"14","author":"ME Farhangian","year":"2015","unstructured":"Farhangian ME, McMichael AJ, Huang KE, Feldman SR. Treatment of alopecia areata in the United States: a retrospective cross-sectional study. J Drugs Dermatol. 2015;14(9):1012\u20134.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"620_CR126","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","volume":"52","author":"VH Price","year":"2005","unstructured":"Price VH, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol. 2005;52(1):138\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"620_CR127","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/archderm.136.1.124","volume":"136","author":"BH Thiers","year":"2000","unstructured":"Thiers BH. Topical tacrolimus: treatment failure in a patient with alopecia areata. Arch Dermatol. 2000;136(1):124.","journal-title":"Arch Dermatol"},{"issue":"12","key":"620_CR128","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/ijd.13676","volume":"56","author":"KE Jung","year":"2017","unstructured":"Jung KE, Gye JW, Park MK, Park BC. Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata. Int J Dermatol. 2017;56(12):1487\u20138.","journal-title":"Int J Dermatol"},{"issue":"4","key":"620_CR129","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-0031-1273703","volume":"223","author":"A Sauerbrey","year":"2011","unstructured":"Sauerbrey A. Successful immunsuppression in childhood alopecia areata. Klin Padiatr. 2011;223(4):244\u20135.","journal-title":"Klin Padiatr"},{"issue":"8","key":"620_CR130","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1365-4632.2008.03700.x","volume":"47","author":"T Rashidi","year":"2008","unstructured":"Rashidi T, Mahd AA. Treatment of persistent alopecia areata with sulfasalazine. Int J Dermatol. 2008;47(8):850\u20132.","journal-title":"Int J Dermatol"},{"issue":"4","key":"620_CR131","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaad.2006.10.980","volume":"57","author":"O Bakar","year":"2007","unstructured":"Bakar O, Gurbuz O. Is there a role for sulfasalazine in the treatment of alopecia areata? J Am Acad Dermatol. 2007;57(4):703\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"620_CR132","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/0378-6323.45103","volume":"74","author":"S Aghaei","year":"2008","unstructured":"Aghaei S. An uncontrolled, open label study of sulfasalazine in severe alopecia areata. Indian J Dermatol Venereol Leprol. 2008;74(6):611\u20133.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"620_CR133","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/pde.13451","volume":"35","author":"D Yun","year":"2018","unstructured":"Yun D, Silverberg NB, Stein SL. Alopecia areata treated with hydroxychloroquine: a retrospective study of nine pediatric cases. Pediatr Dermatol. 2018;35(3):361\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"620_CR134","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0190-9622(85)70088-6","volume":"12","author":"AJ Mitchell","year":"1985","unstructured":"Mitchell AJ, Douglass MC. Topical photochemotherapy for alopecia areata. J Am Acad Dermatol. 1985;12(4):644\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"620_CR135","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/ijt.ijt_95_17","volume":"10","author":"B Majumdar","year":"2018","unstructured":"Majumdar B, De A, Ghosh S, et al. \u201cTurban PUVAsol:\u201d a simple, novel, effective, and safe treatment option for advanced and refractory cases of alopecia areata. Int J Trichol. 2018;10(3):124\u20138.","journal-title":"Int J Trichol"},{"issue":"12","key":"620_CR136","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1365-4632.2005.02542.x","volume":"44","author":"TY Yoon","year":"2005","unstructured":"Yoon TY, Kim YG. Infant alopecia universalis: role of topical PUVA (psoralen ultraviolet A) radiation. Int J Dermatol. 2005;44(12):1065\u20137.","journal-title":"Int J Dermatol"},{"issue":"12","key":"620_CR137","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/archderm.1983.01650360021007","volume":"119","author":"AL Claudy","year":"1983","unstructured":"Claudy AL, Gagnaire D. PUVA treatment of alopecia areata. Arch Dermatol. 1983;119(12):975\u20138.","journal-title":"Arch Dermatol"},{"issue":"6","key":"620_CR138","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/09546634.2018.1543847","volume":"30","author":"M El-Mofty","year":"2019","unstructured":"El-Mofty M, Rasheed H, El-Eishy N, et al. A clinical and immunological study of phototoxic regimen of ultraviolet A for treatment of alopecia areata: a randomized controlled clinical trial. J Dermatol Treat. 2019;30(6):582\u20137.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"620_CR139","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-4362.1983.tb03377.x","volume":"22","author":"MA Amer","year":"1983","unstructured":"Amer MA, El Garf A. Photochemotherapy and alopecia areata. Int J Dermatol. 1983;22(4):245\u20136.","journal-title":"Int J Dermatol"},{"issue":"1","key":"620_CR140","first-page":"59","volume":"17","author":"S Boonyaleepun","year":"1999","unstructured":"Boonyaleepun S, Boonyaleepun C, Schlactus JL. Effect of IVIG on the hair regrowth in a common variable immune deficiency patient with alopecia universalis. Asian Pac J Allergy Immunol. 1999;17(1):59\u201362.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"4","key":"620_CR141","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000288561","volume":"56","author":"H Teshima","year":"1991","unstructured":"Teshima H, Sogawa H, Mizobe K, Kuroki N, Nakagawa T. Application of psychoimmunotherapy in patients with alopecia universalis. Psychother Psychosom. 1991;56(4):235\u201341.","journal-title":"Psychother Psychosom"},{"issue":"9","key":"620_CR142","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15696","volume":"35","author":"DM Toma","year":"2022","unstructured":"Toma DM, Atallah RB, Eldahshan RM. Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata. Dermatol Ther. 2022;35(9): e15696.","journal-title":"Dermatol Ther"},{"issue":"2","key":"620_CR143","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000441250","volume":"232","author":"D Anuset","year":"2016","unstructured":"Anuset D, Perceau G, Bernard P, Reguiai Z. Efficacy and safety of methotrexate combined with low- to moderate-dose corticosteroids for severe alopecia areata. Dermatology. 2016;232(2):242\u20138.","journal-title":"Dermatology"},{"issue":"5","key":"620_CR144","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1590\/abd1806-4841.20142869","volume":"89","author":"M Hammerschmidt","year":"2014","unstructured":"Hammerschmidt M, Mulinari BF. Efficacy and safety of methotrexate in alopecia areata. An Bras Dermatol. 2014;89(5):729\u201334.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"620_CR145","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000339341","volume":"224","author":"C Droitcourt","year":"2012","unstructured":"Droitcourt C, Milpied B, Ezzedine K, et al. Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series. Dermatology. 2012;224(4):369\u201373.","journal-title":"Dermatology"},{"issue":"11","key":"620_CR146","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","volume":"128","author":"EA Olsen","year":"1992","unstructured":"Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol. 1992;128(11):1467\u201373.","journal-title":"Arch Dermatol"},{"issue":"6","key":"620_CR147","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4103\/0378-6323.29346","volume":"72","author":"G Sethuraman","year":"2006","unstructured":"Sethuraman G, Malhotra AK, Sharma VK. Alopecia universalis in Down syndrome: response to therapy. Indian J Dermatol Venereol Leprol. 2006;72(6):454\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"620_CR148","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/ijt.ijt_14_18","volume":"10","author":"AE Kiszewski","year":"2018","unstructured":"Kiszewski AE, Bevilaqua M, De Abreu LB. Mesalazine in the treatment of extensive alopecia areata: a new therapeutic option? Int J Trichology. 2018;10(3):99\u2013102.","journal-title":"Int J Trichology."},{"issue":"6","key":"620_CR149","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/pde.13688","volume":"35","author":"K Sardana","year":"2018","unstructured":"Sardana K, Gupta A, Gautam RK. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK\/STAT inhibitors? Pediatr Dermatol. 2018;35(6):856\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"620_CR150","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/0019-5154.62747","volume":"55","author":"S Das","year":"2010","unstructured":"Das S, Ghorami RC, Chatterjee T, Banerjee G. Comparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in alopecia areata. Indian J Dermatol. 2010;55(2):148\u20139.","journal-title":"Indian J Dermatol"},{"key":"620_CR151","unstructured":"Yoham AL, Casadesus D. Tretinoin\u2014StatPearls\u2014NCBI Bookshelf. 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557478\/. Accessed 12 Sept 2023."},{"issue":"1","key":"620_CR152","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jocd.13465","volume":"20","author":"D Mahgoub","year":"2021","unstructured":"Mahgoub D, Mohye Eldeen R, Saadi D, El-Samanoudy S, Ibrahim S. Clinical and trichoscopic evaluation of trichloroacetic acid 35% vs phenol 88% peels in treatment of alopecia areata. J Cosmet Dermatol. 2021;20(1):143\u20139.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"620_CR153","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1525-1470.1999.pdele65.x","volume":"16","author":"FM Camacho","year":"1999","unstructured":"Camacho FM, Garc\u00eda-Hern\u00e1ndez MJ. Zinc aspartate, biotin, and clobetasol propionate in the treatment of alopecia areata in childhood. Pediatr Dermatol. 1999;16(4):336\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"620_CR154","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/dth.12215","volume":"28","author":"C Lux-Battistelli","year":"2015","unstructured":"Lux-Battistelli C. Combination therapy with zinc gluconate and PUVA for alopecia areata totalis: an adjunctive but crucial role of zinc supplementation. Dermatol Ther. 2015;28(4):235\u20138.","journal-title":"Dermatol Ther"},{"issue":"3","key":"620_CR155","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/14764172.2017.1383617","volume":"20","author":"S Fenniche","year":"2018","unstructured":"Fenniche S, Hammami H, Zaouak A. Association of khellin and 308-nm excimer lamp in the treatment of severe alopecia areata in a child. J Cosmet Laser Ther. 2018;20(3):156\u20138.","journal-title":"J Cosmet Laser Ther"},{"key":"620_CR156","unstructured":"Clinical Trials. National Library of Medicine. http:\/\/www.clinicaltrials.gov. Accessed 12 Sept 2023."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00620-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T04:24:59Z","timestamp":1714969499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00620-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00620-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"11 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"LLW contributed to the design and drafting of the manuscript. DSM contributed to the conception and revision of the manuscript. DBM and ELN contributed to the design and revision of the work. All authors approved the final version of the manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}